Hsc-clinicians-anesthesia

Download

hsc-clinicians-anesthesia@lists.umanitoba.ca

March 2026

2 participants
2 discussions

FW: Glycopyrrolate Vial Size Change
by Jashandeep Gill 09 Mar '26

09 Mar '26

Caution! This message was sent from outside the University of Manitoba. Sent on behalf of Robert Hardy. Please see the email below. From: Robert Hardy <rhardy3(a)manitoba-physicians.ca> Hi Everyone, As you may have already noticed, pharmacy has started supplying glycopyrrolate 0.2 mg/mL x 2 mL vials, in place of our previous 1 mL vials with the same concentration. Unfortunately, I have seen both vial sizes stocked together in the same drawer, so please be vigilant to ensure that you have drawn up the volume intended. The 2 mL vials are actually less expensive than the 1 mL vials, which prompted the switch. My apologies that this change was not communicated sooner. Kind regards, Rob Hardy Disclaimer : This email (including any attachments or enclosed documents) is intended for the addressee(s) only and may contain privileged, proprietary or confidential information. Any unauthorized use, disclosure, distribution, copying or dissemination is strictly prohibited. If you receive this email in error, please notify the sender immediately, return the original (if applicable) and delete the email. Avis : Le pr?sent courriel (y compris toute pi?ce jointe) est destin? ? la personne ou aux personnes ? qui il est adress?, et peut contenir des renseignements confidentiels, priv?s ou prot?g?s par un privil?ge juridique. Toute utilisation, divulgation, distribution, copie ou diffusion non autoris?e est strictement d?fendue. Si vous avez re?u le pr?sent courriel par erreur, veuillez en informer imm?diatement l'exp?diteur, retourner l'original (le cas ?ch?ant) et supprimer ce courriel.

1 0

April 1 to July 3 HSC Call schedule
by Genevieve Krahn 05 Mar '26

05 Mar '26

Caution! This message was sent from outside the University of Manitoba. Good afternoon all, I will be publishing the HSC call before end of day today for the range of April 1- July 3. We are currently working the daytime slates (equalizing the Gyne assignments as well as the desirable slates etc), hoping to publish those by the end of next week. 1 - I have noticed there have been added requests in the system since I have been working on the call schedule. I will go back and offer those slates up for grabs for those affected. 2 - Please note I have manually assigned Main OR slates for when you are on Back-up. If you are picking up Back-up call from someone else, your current day assignment may be in Notre Dame or Women's. The day shift is not auto-locked to follow the call slate. 3 - For those on Step-down I have assigned you to either Thoracic, HPB or Vascular when on PCUS-B. These will count towards your desirable slate allocation. So you will get 2 in one week and then maybe none for the next 2 weeks etc. Thanks, Gen Genevieve Krahn (she/her) Administrative Manager WRHA Anesthesia AE2-21, Harry Medovy House 671 William Avenue R3E 0Z2 Phone: (204)787-8980 Fax: (204)787-4291 Email: Gkrahn2(a)wrha.mb.ca<mailto:Gkrahn2@wrha.mb.ca> The Winnipeg Regional Health Authority acknowledges that it provides health services in facilities located in Treaty 1 and Treaty 5 territories, the homelands of the Mètis Nation and the original lands of the Inuit people. The WRHA respects and acknowledges harms and mistakes, and we dedicate ourselves to collaborate in partnership with First Nation Mètis and Inuit people in the spirit of reconciliation. [Facebook-logo]@winnipegregionalhealthauthority [twitter.png] @WinnipegRHA [website-logo-png] www.wrha.mb.ca<http://www.wrha.mb.ca/> REMOTE WORK DAY: PLANNED ABSENCES: March 20, 30 Disclaimer : This email (including any attachments or enclosed documents) is intended for the addressee(s) only and may contain privileged, proprietary or confidential information. Any unauthorized use, disclosure, distribution, copying or dissemination is strictly prohibited. If you receive this email in error, please notify the sender immediately, return the original (if applicable) and delete the email. Avis : Le présent courriel (y compris toute pièce jointe) est destiné à la personne ou aux personnes à qui il est adressé, et peut contenir des renseignements confidentiels, privés ou protégés par un privilège juridique. Toute utilisation, divulgation, distribution, copie ou diffusion non autorisée est strictement défendue. Si vous avez reçu le présent courriel par erreur, veuillez en informer immédiatement l'expéditeur, retourner l'original (le cas échéant) et supprimer ce courriel.

1 0